Nuclear Medicine and Biology
Volume 34, Issue 8 , Pages 967-971, November 2007

(E)-[125I]-5-AOIBV: a SPECT radioligand for the vesicular acetylcholine transporter

  • Patrick Emond

      Affiliations

    • INSERM U619, 37000 Tours, France
    • Université François-Rabelais de Tours, CHRU, Hôpital Bretonneau, Service de Médecine nucléaire, 37000 Tours, France
  • ,
  • Sylvie Mavel

      Affiliations

    • INSERM U619, 37000 Tours, France
    • Université François-Rabelais de Tours, CHRU, Hôpital Bretonneau, Service de Médecine nucléaire, 37000 Tours, France
    • Corresponding Author InformationCorresponding author. Faculté de Pharmacie, Laboratoire de Biophysique Médicale et Pharmaceutique, 37200 Tours, France. Tel.: +33 2 47 36 72 40; fax: +33 2 47 36 72 24.
  • ,
  • Yolanda Zea-Ponce

      Affiliations

    • INSERM U619, 37000 Tours, France
    • Université François-Rabelais de Tours, CHRU, Hôpital Bretonneau, Service de Médecine nucléaire, 37000 Tours, France
  • ,
  • Michael Kassiou

      Affiliations

    • Discipline of Medical Radiation Sciences, Brain and Mind Research Institute, University of Sydney, NSW 2050, Australia
    • School of Chemistry, University of Sydney, NSW 2006, Australia
  • ,
  • Lucette Garreau

      Affiliations

    • INSERM U619, 37000 Tours, France
    • Université François-Rabelais de Tours, CHRU, Hôpital Bretonneau, Service de Médecine nucléaire, 37000 Tours, France
  • ,
  • Sylvie Bodard

      Affiliations

    • INSERM U619, 37000 Tours, France
    • Université François-Rabelais de Tours, CHRU, Hôpital Bretonneau, Service de Médecine nucléaire, 37000 Tours, France
  • ,
  • Marie-Laure Drossard

      Affiliations

    • INSERM U619, 37000 Tours, France
    • Université François-Rabelais de Tours, CHRU, Hôpital Bretonneau, Service de Médecine nucléaire, 37000 Tours, France
  • ,
  • Sylvie Chalon

      Affiliations

    • INSERM U619, 37000 Tours, France
    • Université François-Rabelais de Tours, CHRU, Hôpital Bretonneau, Service de Médecine nucléaire, 37000 Tours, France
  • ,
  • Denis Guilloteau

      Affiliations

    • INSERM U619, 37000 Tours, France
    • Université François-Rabelais de Tours, CHRU, Hôpital Bretonneau, Service de Médecine nucléaire, 37000 Tours, France

Received 12 April 2007; received in revised form 13 July 2007; accepted 16 July 2007. published online 20 September 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This work was supported by INSERM. This study was funded in part by the EC-FP6-project DiMI, LSHB-CT-2005-512146.

PII: S0969-8051(07)00191-6

doi:10.1016/j.nucmedbio.2007.07.011

Nuclear Medicine and Biology
Volume 34, Issue 8 , Pages 967-971, November 2007